Cargando…
Digital quantitative assessment of PD-L1 using digital spatial profiling
The assessment of programmed death 1 ligand 1 (PD-L1) expression by Immunohistochemistry (IHC) is the US Food and Drug Administration (FDA)-approved predictive marker to select responders to checkpoint blockade anti-PD-1/PD-L1 axis immunotherapies. Different PD-L1 immunohistochemistry (IHC) assays u...
Autores principales: | Gupta, Swati, Zugazagoitia, Jon, Martinez-Morilla, Sandra, Fuhrman, Kit, Rimm, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502436/ https://www.ncbi.nlm.nih.gov/pubmed/32249818 http://dx.doi.org/10.1038/s41374-020-0424-5 |
Ejemplares similares
-
Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy
por: Martinez-Morilla, Sandra, et al.
Publicado: (2020) -
Standardization of PD-L1 immunohistochemistry
por: Martinez-Morilla, Sandra, et al.
Publicado: (2021) -
Digital spatial profiling of melanoma shows CD95 expression in immune cells is associated with resistance to immunotherapy
por: Martinez-Morilla, Sandra, et al.
Publicado: (2023) -
Antibody validation for protein expression on tissue slides: a protocol for immunohistochemistry
por: MacNeil, Tyler, et al.
Publicado: (2020) -
Quantitative RNA assessment and long-term stability in the FFPE tumor samples using Digital Spatial Profiler
por: Gupta, S., et al.
Publicado: (2021)